Difference between revisions of "Hematopoetic progenitor cells, cord blood (Hemacord)"
m |
Warner-admin (talk | contribs) m (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information") |
||
(5 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | |||
==General information== | ==General information== | ||
− | Class/mechanism: Hematopoietic stem/progenitor cells isolated from cord blood; hematopoetic progenitor cells, cord blood (HPC-C) migrate to the bone marrow, engraft, divide, and produce mature blood cells. | + | Class/mechanism: Hematopoietic stem/progenitor cells isolated from cord blood; hematopoetic progenitor cells, cord blood (HPC-C) migrate to the bone marrow, engraft, divide, and produce mature blood cells. For use in unrelated donor hematopoietic progenitor cell transplantation.<ref name="insert">[http://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM279612.pdf Hematopoetic progenitor cells, cord blood (Hemacord) package insert]</ref><ref>[https://hemonc.org/docs/packageinsert/hematopoeticprogenitorcellscordblood.pdf Hematopoetic progenitor cells, cord blood (Hemacord) package insert (locally hosted backup)]</ref> |
<br>Route: IV | <br>Route: IV | ||
<br>Extravasation: No information | <br>Extravasation: No information | ||
− | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.<ref name="insert"></ref> |
==Patient drug information== | ==Patient drug information== | ||
Line 18: | Line 17: | ||
[[Category:Cellular therapy]] | [[Category:Cellular therapy]] | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
− | [[Category: | + | [[Category:FDA approved in 2011]] |
Latest revision as of 01:00, 29 June 2024
General information
Class/mechanism: Hematopoietic stem/progenitor cells isolated from cord blood; hematopoetic progenitor cells, cord blood (HPC-C) migrate to the bone marrow, engraft, divide, and produce mature blood cells. For use in unrelated donor hematopoietic progenitor cell transplantation.[1][2]
Route: IV
Extravasation: No information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.[1]
Patient drug information
No information available.
Also known as
- Brand name: Hemacord